Display options
Cite
Fauconnier A. Regulating phage therapy: The biological master file concept could help to overcome regulatory challenge of personalized medicines. EMBO Rep. 2017;18(2):198-200doi: 10.15252/embr.201643250.
Fauconnier, A. (2017). Regulating phage therapy: The biological master file concept could help to overcome regulatory challenge of personalized medicines. EMBO reports, 18(2), 198-200. https://doi.org/10.15252/embr.201643250
Fauconnier, Alan. "Regulating phage therapy: The biological master file concept could help to overcome regulatory challenge of personalized medicines." EMBO reports vol. 18,2 (2017): 198-200. doi: https://doi.org/10.15252/embr.201643250
Fauconnier A. Regulating phage therapy: The biological master file concept could help to overcome regulatory challenge of personalized medicines. EMBO Rep. 2017 Feb;18(2):198-200. doi: 10.15252/embr.201643250. Epub 2017 Jan 12. PMID: 28082313; PMCID: PMC5286392.
Copy Download .nbib Format: NLM
Share it on

EMBO Rep. 2017 Feb;18(2):198-200. doi: 10.15252/embr.201643250. Epub 2017 Jan 12.

Regulating phage therapy: The biological master file concept could help to overcome regulatory challenge of personalized medicines.

EMBO reports

Alan Fauconnier

Affiliations

  1. Culture in vivo ASBL, Nivelles, Belgium.

PMID: 28082313 PMCID: PMC5286392 DOI: 10.15252/embr.201643250

[No abstract available.]

References

  1. Pharm Res. 2011 Apr;28(4):934-7 - PubMed
  2. Bacteriophage. 2013 Apr 1;3(2):e24872 - PubMed
  3. Arch Immunol Ther Exp (Warsz). 2014 Apr;62(2):117-29 - PubMed
  4. Future Microbiol. 2013 Jun;8(6):769-83 - PubMed
  5. J Antimicrob Chemother. 2016 Aug;71(8):2071-4 - PubMed
  6. Future Microbiol. 2007 Oct;2(5):485-91 - PubMed
  7. EMBO Rep. 2013 Nov;14(11):951-4 - PubMed
  8. Nat Rev Microbiol. 2015 Dec;13(12 ):777-86 - PubMed

MeSH terms

Publication Types